» Articles » PMID: 19050970

Positive Lymph Node Ratio is an Independent Prognostic Factor in Gastric Cancer After D2 Resection Regardless of the Examined Number of Lymph Nodes

Overview
Journal Ann Surg Oncol
Publisher Springer
Specialty Oncology
Date 2008 Dec 4
PMID 19050970
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this study was to clarify the outcome of the ratio between metastatic and examined lymph nodes (N ratio) in gastric cancer patients with < or =15 examined lymph nodes after D2 lymphadenectomy. A retrospective study was performed in 906 patients with gastric cancer who had undergone D2 resection. Patients with < or =15 examined lymph nodes (group 1, n = 729) and those with >15 lymph nodes (group 2, n = 177) were analyzed separately. N ratio categories were identified as follows: N ratio 0, 0%; N ratio 1, 1% to 9%; N ratio 2, 10% to 25%; N ratio 3, >25%. Univariate analysis found that both the tumor, node, metastasis system (N staging system) and N ratio system well classified patients with significantly different prognosis. By multivariate analysis, only the N ratio classification was retained as an independent prognostic factor in both group 1 and 2 compared with the N stage system. Furthermore, when patients were divided into four groups according to the number of lymph nodes examined (1 to 3, 4 to 7, 8 to 11, and 12 to 15), the 5-year survival rates remained similar between groups according to the same N ratio (p > .05). Positive N ratio classification is a better prognostic tool compared with N staging system after D2 resection in patients with gastric cancer. It can prevent stage migration and can be used regardless of the examined number of lymph nodes.

Citing Articles

Development of a Prognostic Nomogram for Overall Survival in Gastric Cancer Patients Who Underwent Adjuvant Chemoradiotherapy.

Yilmaz M, Hurmuz P, Dag O, Yigit E, Ozyurek Y, Avci H J Gastrointest Cancer. 2025; 56(1):39.

PMID: 39798000 DOI: 10.1007/s12029-025-01167-2.


RATIO OF METASTATIC LYMPH NODES VS. RESECTED LYMPH NODES (N-RATIO) HAS PROGNOSTIC IMPLICATIONS IN GASTRIC CANCER.

Porto B, Pereira M, Ramos M, Dias A, Lopasso F, Carneiro DAlbuquerque L Arq Bras Cir Dig. 2024; 37:e1824.

PMID: 39319897 PMC: 11419286. DOI: 10.1590/0102-6720202400031e1824.


Refining gastric cancer staging: examining the interplay between number and anatomical location of metastatic lymph nodes - a retrospective multi-institutional study.

Jeon C, Park K, Lee H, Kim D, Seo H, Lee J BMC Cancer. 2023; 23(1):1192.

PMID: 38053052 PMC: 10699030. DOI: 10.1186/s12885-023-11653-0.


Development and Validation of Prognostic Nomograms Based on Lymph Node Ratio for Young Patients with Gastric Cancer: A SEER-Based Study.

Chen Y, Tian Z, Wang M, Sun M, Wu J, Wang X Technol Cancer Res Treat. 2023; 22:15330338231157923.

PMID: 37248609 PMC: 10291254. DOI: 10.1177/15330338231157923.


Association of lymph node metastases, grade and extent of mesenteric lymph node dissection in locoregional small intestinal neuroendocrine tumors with recurrence-free survival.

Daskalakis K, Wedin M, Tsoli M, Kogut A, Srirajaskanthan R, Sarras K J Neuroendocrinol. 2022; 34(11):e13205.

PMID: 36385444 PMC: 10078463. DOI: 10.1111/jne.13205.